The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial


Creative Commons License

Kazancioglu H. O., Cakir O., Ak G., Zulfikar B.

TURKISH JOURNAL OF HEMATOLOGY, cilt.30, sa.1, ss.19-24, 2013 (SCI-Expanded, Scopus, TRDizin) identifier identifier

Özet

Objective: To assess the hemostatic efficacy of a new local hemostatic agent, Ankaferd Blood Stopper (ABS), for the control of bleeding following tooth extraction in hemophiliacs.